Cameron Goldstrich’s Post

Making clinical trials more accessible is crucial for improving health outcomes in diverse populations and advancing inclusive medical research. Our recent Site Spotlight sheds light on how EmVenio Research is using technology to achieve these goals. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we explore their unique approach and its impact on underrepresented communities. EmVenio is setting up clinical trial sites in areas with limited research activity and leveraging advanced eClinical solutions, like RealTime-SOMS, to break down barriers and ensure diverse participation in clinical research. For a deeper look into EmVenio's innovative work and future plans, read the full interview here: https://lnkd.in/e4pggsYS #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

Making clinical trials more accessible is crucial for improving health outcomes in diverse populations and advancing inclusive medical research. Our recent Site Spotlight sheds light on how EmVenio Research is using technology to achieve these goals. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we explore their unique approach and its impact on underrepresented communities. EmVenio is setting up clinical trial sites in areas with limited research activity and leveraging advanced eClinical solutions, like RealTime-SOMS, to break down barriers and ensure diverse participation in clinical research. For a deeper look into EmVenio's innovative work and future plans, read the full interview here: https://lnkd.in/guM_jqjZ #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

We are truly honored to serve as the technology backbone for such an innovative clinical research organization... Expanding access to clinical trials is crucial for improving health outcomes and advancing inclusive medical research. In our latest Site Spotlight, we explore how EmVenio Research is using technology to broaden research access and foster diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we explore their innovative business approach and the impactful work they're doing in underserved communities. EmVenio is making a difference by setting up clinical trial sites in areas with little to no prior trial activity and by incorporating advanced eClinical solutions, like the RealTime-SOMS eClinical suite. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's innovative work and future plans: https://lnkd.in/gtRyzy8F #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

Expanding access to clinical trials is crucial for improving health outcomes and advancing inclusive medical research. In our latest Site Spotlight, we explore how EmVenio Research is using technology to broaden research access and foster diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we explore their innovative business approach and the impactful work they're doing in underserved communities. EmVenio is making a difference by setting up clinical trial sites in areas with little to no prior trial activity and by incorporating advanced eClinical solutions, like the RealTime-SOMS eClinical suite. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's innovative work and future plans: https://lnkd.in/gQMHxgSa #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/gvyxpPGY #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/ert6ZQGW #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

Expanding access to clinical trials is essential for ensuring better outcomes for diverse populations and advancing medical research inclusively. In our latest Site Spotlight, discover how EmVenio Research is leveraging technology to expand research access and promote diversity in clinical trials. In an interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio, we dive into their innovative business model and how they're making a significant impact in underrepresented communities. From establishing clinical trial sites in trial-naïve areas to utilizing the RealTime-SOMS eClinical suite, EmVenio is breaking barriers and ensuring more inclusive research. 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔: 𝑬𝒙𝒑𝒂𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒂𝒄𝒉: EmVenio's strategic locations in underrepresented communities make trials more accessible, reducing travel and scheduling barriers for participants. 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒛𝒊𝒏𝒈 𝑫𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚: By bringing trials to diverse populations, EmVenio enhances patient engagement and data representativeness. 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏: EmVenio partners with local stakeholders to build trust and promote health within communities. 𝑬𝒎𝒃𝒓𝒂𝒄𝒊𝒏𝒈 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚: Leveraging advanced eClinical technology, like the RealTime-SOMS platform, EmVenio is able to reach a broader and more diverse participant pool. The platform's capabilities in efficient recruitment, scheduling, and participant engagement are pivotal in breaking down barriers, making it easier for diverse populations to participate in clinical trials. Read the full interview to learn more about EmVenio's groundbreaking work and their plans for the future: https://lnkd.in/ggCK5CRW #SiteSpotlight #DiversityInResearch #ClinicalTrials #InnovativeSolutions #HealthEquity #CommunityEngagement #EmVenioResearch #RealTimeClinicalSolutions

🎧 Revolutionizing Medicine with Cell-Based Therapies with Crystal Nyitray Crystal Nyitray and Julie uncover: • The potential of encapsulated cell replacement therapy to revolutionize medicine. • How startups have the luxury of risk and can experiment with emerging technologies to benefit everyone. • Embracing inexperience as a strength and building networks from scratch. • How being comfortable with being different can lead to disruptive innovation and impactful change. ⬇ Tag a colleague who is in the medical field ⬇ #healthcare #executivewomen #howwomenlead #howwomeninspire #howwomeninvest https://lnkd.in/gTvUkjtN

🎧 Revolutionizing Medicine with Cell-Based Therapies with Encellin Founder, Crystal Nyitray Crystal Nyitray and Julie uncover: • The potential of encapsulated cell replacement therapy to revolutionize medicine. • How startups have the luxury of risk and can experiment with emerging technologies to benefit everyone. • Embracing inexperience as a strength and building networks from scratch. • How being comfortable with being different can lead to disruptive innovation and impactful change. ⬇ Tag a colleague who is in the medical field ⬇ #healthcare #executivewomen #howwomenlead #howwomeninspire #howwomeninvest https://lnkd.in/gTvUkjtN

So important to design #clinical #tech with the #site perspective in mind.